Загрузка...
Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Research Foundation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3342006/ https://ncbi.nlm.nih.gov/pubmed/22566956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2012.00075 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|